Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes

Ophthalmologica

Volumn 223, Issue 3, 2009, Pages 188-191

  Nam, Dong Heun ^a   Oh, Jaeryung ^b   Roh, Joon Ho ^a   Huh, Kuhl ^b,c  

^a Gachon University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Diabetic retinopathy; Epiretinal membrane; Pigment epithelium derived factor; Vascular endothelial growth factor

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC EPIRETINAL MEMBRANE; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; HUMAN; NONDIABETIC EPIRETINAL MEMBRANE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VITREORETINOPATHY; VITREOUS BODY;

AGED; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; EYE PROTEINS; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; PLATELET-DERIVED GROWTH FACTOR; SERPINS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREORETINOPATHY, PROLIFERATIVE;

EID: 58949095224     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000198686     Document Type: Article

References (17)

1. McLeod D, Hiscott PS, Grierson I: Age-related cellular proliferation at the vitreoretinal juncture. Eye 1987;1:263-281.
2. Smiddy WE, Maguire AM, Green WR, Michels RG, De la Cruz Z, Enger C, Jaeger M, Rice TA: Idiopathic epiretinal membranes: ultrastructural characteristics and clinico-pathologic correlation. Ophthalmology 1989;96:811-821.
3. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L: Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-872.
4. Campochiaro PA, Hackett SF, Vinores SA, Freund J, Csaky C, LaRochelle W, Henderer J, Johnson M, Rodriguez IR, Friedman Z, Derevjanik N, Dooner J: Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci 1994;107:2459-2469.
5. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J: Vasculotropin/ vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995;164:385-394.
6. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA: Localization of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997;81:919-926.
7. 1, TGF-ß receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000;41:2336-2342.
8. Matsuoka M, Ogata N, Minamino K, Matsumura M: Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy. Jpn J Ophthalmol 2006;50:116-120.
9. Distler JHW, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O: Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003;47:149-161.
10. Gao G, Li Y, Fant J, Crosson CE, Becerra SP, Ma J: Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in Brown Norway and Sprague-Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes 2002;51:1218-1225.
11. Armstrong D, Augustin AJ, Spengler R, Al-Jada A, Nickola T, Grus F, Koch F: Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998;212:410-414.
12. Schneeberger SA, Hjelmeland LM, Tucker RP, Morse LS: Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Am J Ophthalmol 1997;124: 447-454.
13. Abu El-Asrar AM, Missotten L, Geboes K: Expression of hypoxia-inducible factor-1 alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol 2007;91:822-826.
14. Andrews A, Balciunaite E, Leong FL, Tall-quist M, Soriano P, Refojo M, Kazlauskas A: Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1999;40:2683-2689.
15. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M: PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994; 125:917-928.
16. Lindahl P, Johansson BR, Leveen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997;277:242-245.
17. Pepper MS: Transforming growth factor-ß; vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8:21-43.